First Manhattan’s Entellus Medical ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-145,000
Closed -$3.54M – 1525
2017
Q4
$3.54M Sell
145,000
-28,700
-17% -$552K 0.02% 309
2017
Q3
$3.21M Hold
173,700
– – 0.02% 308
2017
Q2
$2.88M Buy
+173,700
New +$2.42M 0.02% 313

First Manhattan's ENTL Position: Q1 2018 in Review

First Manhattan sold out of Entellus Medical (ENTL) in Q1 2018, closing a stake of 145,000 shares — an estimated $3.54M sold.

First Manhattan first reported a position in ENTL in Q2 2017 and held it in 3 quarters. The position peaked at $3.54M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • First Manhattan reported no remaining Entellus Medical position as of Q1 2018 after selling out during the quarter.
  • First Manhattan sold 145,000 Entellus Medical shares in Q1 2018, an estimated $3.54M.
  • First Manhattan first reported a position in Entellus Medical in Q2 2017 and held it in 3 quarters.
  • First Manhattan's Entellus Medical position peaked at $3.54M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Entellus Medical as of Q1 2018.

Based on First Manhattan's 13F filing for Q1 2018, filed 20 Apr 2018.